PTGX
$128.75-5.71%
Protagonist Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.01%Russell 3000 0.010%
Protagonist Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Protagonist Therapeutics Inc. total returns by year (2017–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $87.34 | $128.75 | 0.0% | +47.4% | |
| 2025 | $38.60 | $87.34 | 0.0% | +126.3% | |
| 2024 | $22.93 | $38.60 | 0.0% | +68.3% | |
| 2023 | $10.91 | $22.93 | 0.0% | +110.2% | |
| 2022 | $34.20 | $10.91 | 0.0% | -68.1% | |
| 2021 | $20.16 | $34.20 | 0.0% | +69.6% | |
| 2020 | $7.05 | $20.16 | 0.0% | +186.0% | |
| 2019 | $6.73 | $7.05 | 0.0% | +4.8% | |
| 2018 | $20.80 | $6.73 | 0.0% | -67.6% | |
| 2017 | $21.99 | $20.80 | 0.0% | -5.4% |
- Annualized
- +26.4%
- 2017–2026
- Average year
- +47.1%
- 9 full years
- Best year
- +186.0%
- 2020
- Worst year
- -68.1%
- 2022
- Positive years
- 6/9
- 67% up
Annualized (CAGR)
+26.4%
2017–2026
Average year
+47.1%
9 full years
Best year
+186.0%
2020
Worst year
-68.1%
2022
Positive years
6/9
67% up
Total return by period#
Annual
-100%0%100%
2017-5.4%'17
2018-68%'18
2019+4.8%'19
2020+186%'20
2021+70%'21
2022-68%'22
2023+110%'23
2024+68%'24
2025+126%'25
2026+47%'26
Methodology#
Total returns, dividends reinvested, measured on PTGX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Protagonist Therapeutics Inc.'s average annual return?
- Since 2017, Protagonist Therapeutics Inc. (PTGX) has returned about 26.4% a year (the compound annual growth rate) and an average calendar-year return of 47.1%.
- What were Protagonist Therapeutics Inc.'s best and worst years?
- Over 2017–2026, the best year was 2020 (+186.0%) and the worst was 2022 (-68.1%).
- How often is Protagonist Therapeutics Inc. up in a year?
- 6 of the 9 full years since 2017 were positive — about 67% of the time.
More on Protagonist Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
